Jump to content
RemedySpot.com

RESEARCH - Type 1 diabetes associated with anti-CCP-positive RA

Rate this topic


Guest guest

Recommended Posts

Guest guest

Type 1 Diabetes Associated With Anti-CCP-Positive Rheumatoid Arthritis

NEW YORK (Reuters Health) Mar 18 - People with type 1 diabetes

mellitus have an increased risk of a specific form of rheumatoid

arthritis (RA), anti-cyclic citrullinated peptide (anti-CCP)-positive

RA, according to the findings of a large case-control study of Swedish

adults published in the March issue of the journal Arthritis &

Rheumatism.

In addition, both diseases were associated with the 620W allele of the

protein tyrosine phosphatase N22 (PTPN22) gene, prompting the

researchers to suggest that this gene variant might " represent a

common pathway for the pathogenesis of these two diseases. "

" This provides the first evidence for an association between these

diseases at a population level, " coauthor Dr. P. Liao of

Brigham and Women's Hospital, Boston, told Reuters Health. " The fact

that a genetic factor like PTPN22 contributes to the risk of both RA

and type 1 diabetes suggests that these diseases may share a common

disease pathway. Identification of important, shared disease mediators

is an important goal for both disease prevention and the development

of therapeutics. "

*************************************

Read the full article here:

http://www.medscape.com/viewarticle/589808

Not an MD

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...